Article 1
Part A of the Annex to Implementing Regulation (EU) No 540/2011 is amended in accordance with the Annex to this Regulation.
Commission Implementing Regulation (EU) No 1136/2013 of 12 November 2013 amending Implementing Regulation (EU) No 540/2011 as regards the extension of the approval periods of the active substances clothianidin, dimoxystrobin, oxamyl and pethoxamid Text with EEA relevance
Data as of 2026-07-04 · Compiled from an official source version. Later amendments or repeals may not be reflected; the official text prevails. · Read the official text ↗
Part A of the Annex to Implementing Regulation (EU) No 540/2011 is amended in accordance with the Annex to this Regulation.
This Regulation shall enter into force on the twentieth day following that of its publication in the Official Journal of the European Union .
ANNEX Part A of the Annex to Implementing Regulation (EU) No 540/2011 is amended as follows: (1) in the sixth column, expiration of approval, of row 116, oxamyl, the date 31 July 2016 is replaced by 31 January 2018; (2) in the sixth column, expiration of approval, of row 121, clothianidin, the date 31 July 2016 is replaced by 31 January 2018; (3) in the sixth column, expiration of approval, of row 122, pethoxamid, the date 31 July 2016 is replaced by 31 January 2018; (4) in the sixth column, expiration of approval, of row 128, dimoxystrobin, the date 30 September 2016 is replaced by 31 January 2018.
Source: EUR-Lex (Publications Office of the EU), © European Union, reuse permitted under Commission Decision 2011/833/EU.